These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
104 related articles for article (PubMed ID: 13227507)
41. Immunologic advantages of emulsified influenza virus vaccines. DAVENPORT FM; HENNESSY AV; BELL JA Mil Med; 1962 Feb; 127():95-100. PubMed ID: 13883722 [No Abstract] [Full Text] [Related]
42. Preliminary results of vaccination against influenza. I. Degree of reactivity and immunogenicity of different anti-influenzal preparations. VAROIAN OV; BOLOTOVSKII VM Zh Mikrobiol Epidemiol Immunobiol; 1962 Nov; 33():57-62. PubMed ID: 13996353 [No Abstract] [Full Text] [Related]
43. [Immunological effectiveness of a method for simultaneous immunization against influenza using live and inactivated vaccines]. Orlov VA; Zhilova GP; Ignat'eva GS; Malikova EV; Efremov BV Vopr Virusol; 1982; 27(3):271-5. PubMed ID: 7123907 [TBL] [Abstract][Full Text] [Related]
44. [Influence of multiplicity of immunizations of children with inactivated influenza vaccine on immune response and the effectiveness of protection]. Slobodniuk AV; Romanenko VV; Utnitskaia OS; Motus TM; Pereverzev AV Zh Mikrobiol Epidemiol Immunobiol; 2002; (4):36-9. PubMed ID: 12449696 [TBL] [Abstract][Full Text] [Related]
45. Modeling the effect of different vaccine effectiveness estimates on the number of vaccine-prevented influenza-associated hospitalizations in older adults. Fry AM; Kim IK; Reed C; Thompson M; Chaves SS; Finelli L; Bresee J Clin Infect Dis; 2014 Aug; 59(3):406-9. PubMed ID: 24803379 [TBL] [Abstract][Full Text] [Related]
47. Effectiveness and safety of influenza vaccination in children: European perspective. Heikkinen T; Heinonen S Vaccine; 2011 Oct; 29(43):7529-34. PubMed ID: 21820481 [TBL] [Abstract][Full Text] [Related]
48. Influenza vaccination in the Americas: Progress and challenges after the 2009 A(H1N1) influenza pandemic. Ropero-Álvarez AM; El Omeiri N; Kurtis HJ; Danovaro-Holliday MC; Ruiz-Matus C Hum Vaccin Immunother; 2016 Aug; 12(8):2206-2214. PubMed ID: 27196006 [TBL] [Abstract][Full Text] [Related]
49. Effect of yearly vaccinations with live, attenuated, cold-adapted, trivalent, intranasal influenza vaccines on antibody responses in children. Bernstein DI; Yan L; Treanor J; Mendelman PM; Belshe R; Pediatr Infect Dis J; 2003 Jan; 22(1):28-34. PubMed ID: 12544405 [TBL] [Abstract][Full Text] [Related]
52. Immunization of children with influenza virus vaccine; clinical observations. DUKES RE; GILLESPIE JB Ill Med J; 1948 May; 93(5):252-4. PubMed ID: 18862299 [No Abstract] [Full Text] [Related]
53. Using reminder/recall systems to improve influenza immunization rates in children with asthma. Jones Cooper SN; Walton-Moss B J Pediatr Health Care; 2013; 27(5):327-33. PubMed ID: 22321581 [TBL] [Abstract][Full Text] [Related]
54. Mid-season influenza vaccine effectiveness for the 2012-2013 influenza season. Eick-Cost AA; Hu Z; Cooper MJ; Sanchez JL; Radin JM; Hawksworth AW; Brice GT; Lloyd LV; Tastad KJ; Zorich SC; MacIntosh VH MSMR; 2013 Mar; 20(3):15-6. PubMed ID: 23550929 [No Abstract] [Full Text] [Related]
55. [Research on the immunity against influenza in the population of Milan in the fall of 1972. Distribution of h.i.a. (hemagglutination inhibition antibodies) against A-Hong Kong-68 and A-England-42-72 viruses and the immunizing effectiveness of current vaccines]. Profeta ML; Bergamini F Boll Ist Sieroter Milan; 1973; 52(1):25-31. PubMed ID: 4714450 [No Abstract] [Full Text] [Related]
56. A serologic recapitulation of past experiences with influenza A; antibody response to monovalent vaccine. DAVENPORT FM; HENNESSY AV J Exp Med; 1956 Jul; 104(1):85-97. PubMed ID: 13332182 [TBL] [Abstract][Full Text] [Related]
57. Serological and prophylactic trials of Asian influenza vaccines in Sweden, 1957. HELLER L; KORLOF B; MORNER J; ZETTERBERG B Bull World Health Organ; 1959; 20(2-3):377-400. PubMed ID: 13651920 [TBL] [Abstract][Full Text] [Related]
58. [Influenza vaccination of immunocompromised patients: safe and effective]. Opstelten W; Rimmelzwaan GF; van Essen GA; Bijlsma JW Ned Tijdschr Geneeskd; 2009; 153():A902. PubMed ID: 19857314 [TBL] [Abstract][Full Text] [Related]
59. Vaccination with Recombinant Parainfluenza Virus 5 Expressing Neuraminidase Protects against Homologous and Heterologous Influenza Virus Challenge. Mooney AJ; Gabbard JD; Li Z; Dlugolenski DA; Johnson SK; Tripp RA; He B; Tompkins SM J Virol; 2017 Dec; 91(23):. PubMed ID: 28931689 [TBL] [Abstract][Full Text] [Related]
60. Clinical and serological response in humans following immunization with Gripax influenza vaccine. Morag A; Levy R; Weil G; Zakay-Rones Z J Med Virol; 1983; 11(1):67-75. PubMed ID: 6834012 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]